MWNA
REGN icon

Marshall Wace North America’s Regeneron Pharmaceuticals REGN Stock Holding History

Marshall Wace North America’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$114M Buy
188,467
+129,839
+221% +$80.6M 0.49% 40
2021
Q2 		$32.7M Buy
58,628
+45,916
+361% +$23.3M 0.14% 156
2021
Q1 		$6.01M Buy
12,712
+10,374
+444% +$5.05M 0.02% 515
2020
Q4 		$1.13M Buy
+2,338
New +$1.26M 0.01% 912
2020
Q3 		– Sell
-54,475
Closed -$34M – 1430
2020
Q2 		$34M Buy
54,475
+43,413
+392% +$24.6M 0.22% 113
2020
Q1 		$5.4M Buy
11,062
+8,433
+321% +$3.48M 0.04% 303
2019
Q4 		$987K Buy
+2,629
New +$885K ﹤0.01% 716
2019
Q1 		– Sell
-131
Closed -$49K – 1843
2018
Q4 		$49K Buy
+131
New +$47.9K ﹤0.01% 1257
2018
Q3 		– Sell
-14,764
Closed -$5.09M – 1291
2018
Q2 		$5.09M Buy
14,764
+5,386
+57% +$1.68M 0.03% 504
2018
Q1 		$3.23M Buy
+9,378
New +$3.26M 0.02% 674
2017
Q2 		– Sell
-1,977
Closed -$767K – 1434
2017
Q1 		$767K Buy
+1,977
New +$733K 0.01% 745
2013
Q4 		$9.84M Buy
+35,766
New +$10.3M 0.21% 115

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Marshall Wace North America's REGN Position: Q3 2021 in Review

Marshall Wace North America increased its Regeneron Pharmaceuticals (REGN) stake by 221% in Q3 2021, buying an estimated $80.6M and bringing the position to 188,467 shares worth $114M. The position accounts for 0.49% of the portfolio, ranked #40.

Marshall Wace North America first reported a position in REGN in Q4 2013 and has held it in 12 quarters since. 1,019 funds tracked by Wall St. Rank hold REGN as of Q3 2021.

  • Marshall Wace North America held 188,467 shares of Regeneron Pharmaceuticals worth $114M as of Q3 2021.
  • Marshall Wace North America bought 129,839 Regeneron Pharmaceuticals shares in Q3 2021, an estimated $80.6M.
  • Regeneron Pharmaceuticals made up 0.49% of Marshall Wace North America's portfolio in Q3 2021, its #40 holding.
  • Marshall Wace North America first reported a position in Regeneron Pharmaceuticals in Q4 2013 and has held it in 12 quarters since.
  • 1,019 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.